Searched for
FIBROMUN
Buy Sun Pharma, target price Rs 2,115: JM FinancialJM Financial has recommended a buy call on Sun Pharmaceutical Industries with a target price of Rs 2115, expecting a significant price incr...- Sun Pharma shines in US, home glow to help company beat industry showThe India business, accounting for a third of the company's total revenues, grew at 11%. This is a volume-led growth aided by new product l...
- Sun Pharma Q2 Results: Profit rises 28% YoY to Rs 3,040 crore, beats estimatesSun Pharmaceutical Q2 FY25 Results: Sun Pharma reported a 28% increase in consolidated net profit for Q2, reaching Rs 3,040 crore, up from ...
- Sun Pharma, Philogen enter exclusive licensing pact for commercialisation of specialty cancer drug FirbomunSun Pharma has signed a global licensing deal with Philogen to commercialize Fibromun, an anti-cancer treatment currently in trial for soft...
Load More